US Patent Issued to University of Mississippi Medical Center on June 30 for "Kidney-targeted drug delivery systems" (Mississippi Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,623, issued on June 30, was assigned to University of Mississippi Medical Center (Jackson, Miss.).

"Kidney-targeted drug delivery systems" was invented by Alejandro R. Chade (Brandon, Miss.) and Gene L. Bidwell III (Jackson, Miss.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition including an elastin-like polypeptide (ELP) coupled to a kidney targeting peptide and a therapeutic agent is provided."

The patent was filed on April 29, 2019, under Application No. 16/397,962.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2F...